Bristol Myers Squibb posts Q3 2025 revenues $12.2 billion
Performance driven by growth portfolio momentum, pipeline advancements, and strategic business development
Performance driven by growth portfolio momentum, pipeline advancements, and strategic business development
Everolimus is an mTOR inhibitor immunosuppressant indicated for the prophylaxis of organ rejection in adult patients in kidney and liver transplantation
It will produce a comprehensive range of dosage forms including tablets, hard gelatin capsules, liquids, injectables, topicals, and beta-lactam products
The event will be attended by 35,000+ industry professionals
Telangana aims to increase the value of the Life Sciences economy from US$ 80 billion to US$ 250 billion by 2030
Nicardipine Hydrochloride in 0.9% Sodium Chloride Injection is indicated for the short-term treatment of hypertension when oral therapy is not feasible or desirable
This innovation reinforces Fredun's commitment to creating a 360 degree pet wellness ecosystem
Subscribe To Our Newsletter & Stay Updated